IDH1 and glioma: In addition, this study showed that the age of IDH1-mutant glioma patients was younger than that of wild-type glioma patients, and the difference was statistically significant, consistent with previous studies, suggesting that young patients are more likely to suffer from IDH1-mutant glioma and that their postoperative survival and clinical prognosis may be more optimistic.